hexamethonium has been researched along with Ocular Hypotension in 2 studies
Hexamethonium: A nicotinic cholinergic antagonist often referred to as the prototypical ganglionic blocker. It is poorly absorbed from the gastrointestinal tract and does not cross the blood-brain barrier. It has been used for a variety of therapeutic purposes including hypertension but, like the other ganglionic blockers, it has been replaced by more specific drugs for most purposes, although it is widely used a research tool.
Ocular Hypotension: Abnormally low intraocular pressure often related to chronic inflammation (uveitis).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| OFFRET, G | 1 |
| VALLETTA, J | 1 |
| COSCAS, G | 1 |
| Wynter-Adams, DM | 1 |
| Simon, OR | 1 |
| Gossell-Williams, MD | 1 |
| West, ME | 1 |
2 other studies available for hexamethonium and Ocular Hypotension
| Article | Year |
|---|---|
[Ocular hypotension induced by hexamethonium].
Topics: Corneal Transplantation; Eye Diseases; Hexamethonium; Hexamethonium Compounds; Humans; Intraocular P | 1963 |
Isolation of a muscarinic alkaloid with ocular hypotensive action from Trophis racemosa.
Topics: Acetylcholine; Alkaloids; Animals; Antihypertensive Agents; Atropine; Carbachol; Dogs; Female; Galla | 1999 |